The inversion time determines when the longitudinal magnetization of cerebrospinal fluid crosses zero. Image acquisition is timed at that null point, so CSF contributes little or no signal, whereas many abnormalities retain detectable signal. This timing is the central contrast mechanism of FLAIR imaging and allows researchers to examine tissue bordering fluid-filled spaces with less CSF interference.
CSF can obscure nearby abnormalities on conventional T2-weighted images. Removing its signal increases the contrast between CSF and adjacent abnormal tissue. As a result, white-matter lesions, edema, demyelinating changes, and stroke-related abnormalities may become more conspicuous, supporting closer assessment of their location and extent within the brain.
Compared with conventional T2-weighted images, FLAIR imaging adds deliberate suppression of cerebrospinal fluid signal. This difference reduces the bright fluid background that can obscure abnormalities near fluid-filled spaces, while many lesions remain detectable. The resulting contrast can make structural pathology easier to recognize, particularly when white-matter or other periventricular changes are being assessed.
A FLAIR acquisition begins with an inversion-recovery pulse sequence, uses a carefully selected inversion time to null the longitudinal magnetization of CSF, and then acquires the image at that timing. The sequence therefore links preparation and readout: appropriate timing is necessary to obtain CSF suppression and the intended contrast between lesions and their background.
In neuroscience, FLAIR imaging supports assessment of white-matter lesions, brain edema, demyelination, stroke-related changes, and other brain pathology. Its value is especially apparent when abnormalities lie near CSF-containing spaces, where conventional T2-weighted contrast may make interpretation more difficult. The resulting images support evaluation of structural changes and their distribution.
FLAIR images help researchers and clinicians characterize structural changes by reducing CSF signal while preserving detectable signal from many lesions. This contrast can clarify abnormalities located near fluid-filled spaces and make their extent more apparent. Consequently, the technique contributes to interpreting edema, demyelination, white-matter pathology, and stroke-related changes in neuroscience research and clinical assessment.